Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review
Số trang: 9
Loại file: pdf
Dung lượng: 486.30 KB
Lượt xem: 10
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Health-related quality of life (HRQoL) is recognized as a component endpoint for cancer therapy approvals. The aim of this review was to evaluate the methodology of HRQoL analysis and reporting in phase III clinical trials of first-line chemotherapy in advanced non-small cell lung cancers (NSCLC).
Nội dung trích xuất từ tài liệu:
Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review
Nội dung trích xuất từ tài liệu:
Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Health-related quality of life Lung cancer Cancer therapy approvals HRQoL analysis Non-small cell lung cancersTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 120 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
13 trang 38 0 0